NDC 0832-0044-89 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0044
- Requested NDC
- 0832-0044-89
- Package NDCs from labels
- 0832-0044-09, 0832-0044-10, 0832-0044-89, 0832-0044-01
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Upsher-Smith Laboratories, LLC | Upsher-Smith Laboratories, LLC | 2020-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| calcium phosphate, dibasic, dihydrate | INACTIVE INGREDIENT | O7TSZ97GEP | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Amneal Pharmaceuticals NY LLC | 02f9b562-6f7f-4783-bb0d-67c318073e1c | 2024-03-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 132c078d-7d31-a6f2-e063-6294a90af095 | 2024-03-08 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 52daa759-3327-461a-8cfc-3c6253df91ec | 2024-03-05 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Teva Pharmaceuticals, Inc. | 47edc328-2444-4ca1-a5c1-7c83141e105c | 2024-03-01 | Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b404a550-0df4-404a-8d10-c35e197ca399 | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 44dc874b-4377-46eb-ae32-8d84c9c4d4ae | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 498a9b21-34b9-4373-930b-5ed43201a345 | 2024-01-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | e8958997-f098-44ce-8c21-b7064d1a962e | 2024-01-09 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 55bfd9ea-b474-4863-8fae-1b720d91034c | 2024-01-07 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Lupin Pharmaceuticals, Inc. | a97fefa6-99e6-4eb7-9393-ab2252a2c7d8 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine, Valsartan and Hydrochlorothiazide | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Lupin Pharmaceuticals, Inc. | 35086164-bf92-4b3c-9845-f8cd7464c7d6 | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 900024f4-23d6-4505-81db-4f643e12858c | 2023-12-04 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 5c50c3fe-afe5-459e-95c0-c9af4cbb6909 | 2023-11-13 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 89d8d490-3a9c-40f2-86b7-94b5101dd09a | 2023-10-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 4512feee-a09d-4244-bc03-c43193e53a0e | 2023-09-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | f77db79c-c998-4b63-9984-4cf245f188a7 | 2023-09-10 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d830173d-7676-4490-ab3d-d3515df9ad2e | 2023-09-07 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 5dfcba1f-91c4-4ca5-8a98-fc4fdb2f7ee1 | 2023-09-07 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 69a887ab-95cd-4b81-80ee-02e20eebf65b | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.